Rubicon crosses the chromosome | GenomeWeb

Rubicon crosses the chromosome

Premium

SNP scoring on the cheap. Personalized medicine. If nothing else, startup Rubicon Genomics has the industry buzzwords down pat.

The Ann Arbor, Mich., company, based on PCR-alternative DNA amplification technology, was founded in 1998 by Vladimir Makarov and John Langmore. Rubicon also focuses on identifying SNPs — and new CEO Thomas Collet, who came from healthcare venture fund Tullis-Dickerson, says he hopes to target its SNP scoring technology toward applications in personalized medicine.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.